Maze Therapeutics, Inc. · NASDAQ:MAZE
Frazier Life Sciences Public Fund, L.P. reported a 9.00% stake in Maze Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Frazier Life Sciences Public Fund, L.P. reported a 9.00% stake in Maze Therapeutics, Inc., 4,342,266 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 9.00%
- Shares
- 4,342,266
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 9.00% | 4,342,266 |
| FHMLSP, L.P. | 9.00% | 4,342,266 |
| FHMLSP, L.L.C. | 9.00% | 4,342,266 |
| Frazier Life Sciences X, L.P. | 0.20% | 75,982 |
| FHMLS X, L.P. | 0.20% | 75,982 |
| FHMLS X, L.L.C. | 0.20% | 75,982 |
| Frazier Life Sciences XI, L.P. | 0.30% | 149,026 |
| FHMLS XI, L.P. | 0.30% | 149,026 |
| FHMLS XI, L.L.C. | 0.30% | 149,026 |
| Frazier Life Sciences XII, L.P. | 0% | 0 |
| FHMLS XII, L.P. | 0% | 0 |
| FHMLS XII, L.L.C. | 0% | 0 |
| James N. Topper | 0.20% | 75,982 |
| Patrick J. Heron | 0.20% | 75,982 |
Source
Related
- Maze Therapeutics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2025
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Apr 29, 2025
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Apr 29, 2025
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Feb 10, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026